Skip to main content

Advertisement

Peer Review reports

From: Combined immune checkpoint inhibitor therapy with nivolumab and ipilimumab causing acute-onset type 1 diabetes mellitus following a single administration: two case reports

Original Submission
19 Aug 2019 Submitted Original manuscript
28 Sep 2019 Reviewed Reviewer Report - Kenji Ashida
30 Sep 2019 Reviewed Reviewer Report - Hideaki Miyoshi
7 Oct 2019 Reviewed Reviewer Report - BRIGITTE VELKENIERS
3 Nov 2019 Author responded Author comments - Marco Zezza
Resubmission - Version 2
3 Nov 2019 Submitted Manuscript version 2
12 Nov 2019 Reviewed Reviewer Report - Kenji Ashida
20 Nov 2019 Reviewed Reviewer Report - Hideaki Miyoshi
25 Nov 2019 Reviewed Reviewer Report - BRIGITTE VELKENIERS
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
2 Dec 2019 Editorially accepted
23 Dec 2019 Article published 10.1186/s12902-019-0467-z

You can find further information about peer review here.

Back to article page